CT-scan screening for heart disease fails to show benefit
March 23, 2015- Interviewed by Steven E. Greer, MD
We interviewed the Principal Investigator of the PROMISE trial, Pamela Douglas, MD from Duke. The trial was NIH-funded and randomized 10,000 patients to receive either CT-scan technology to evaluate new onset chest pain, or more traditional screening methods. The study failed to demonstrate a benefit to the CT-scan technologies.
We asked her whether there was an “oculostenotic reflex” caused by the CT-scans that led to more PCI and CABG. We also asked about the radiation dosages.
Cardiac surgery, Cardiology, Cardiology/interventional, Duke, Late Breaking Data, Medical Devices, NEJM, Radiology | apples49 | 
April 14, 2015 12:35 am
No Comments
No comments yet.
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.
